Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Waanders, Angela
Associate Professor
Bio
I am a pediatric neuro-oncologist with experience in genomics, molecular biology, clinical informatics, and biobanking. My bench based research focus was on molecular characterization of genomic disc... [more]
Walterhouse, David O.
Professor
Bio
As a member of the soft tissue sarcoma committee of the Children's Oncology Group (COG), my primary clinical research interest lies in the area of clinical trials for pediatric patients... [more]
Walz, Amy
Assistant Professor
Bio
My clinical focus centers on the treatment of pediatric solid tumor patients, including those with renal tumors, liver tumors, germ cell tumors, and sarcomas. Through my work with the Children's ... [more]
Wayne, Jeffrey
Professor
Bio
Dr. Wayne is interested in studying the optimal multimodality treatment strategies for melanoma, soft tissue sarcoma and tumors of the upper gastrointestinal tract. Dr. Wayne also has an interest in s... [more]
Wei, Jian-Jun
Professor
Bio
My research interests focus on the histological and phenotypical interpretation of human cancer. As a physician scientist trained in gynecological pathology, my research goal is to discover and develo... [more]
Weinstein, Joanna L.
Associate Professor
Bio
My clinical and research areas of interest include RETINOBLASTOMA, LYMPHOMAS(both Non-Hodgkin and Hodgkin subtypes), and the HISTIOCYTOSES. Our retinoblastoma team includes oncologists, oph... [more]
Winter, Jane N.
Professor
Bio
Winter's clinical and research interests focus on the malignant lymphomas (both Hodgkin and non-Hodgkin), particularly the development of novel therapies and the investigation of clinical and biologic... [more]